Hypoventilation Management Market

Hypoventilation management sales will rise through 2036, driven by chronic obstructive pulmonary disease at 39.6% of the disease type segment in 2026. Non-invasive mechanical ventilation leads the treatment segment with a 46.8% share. The market is projected to reach USD 8.3 billion in 2026 and USD 13.61 billion by 2036.